In addition to seeking Novel Food approval in the EU, the company is also seeking GRAS status in the US.

According to a new study on PEKILO®Pet, the alternative protein can help enhance gut microbiome diversity.

Leveraging $39 million in funding, the company’s facility will help meet the need for more sustainable proteins. 

The facility will produce PEKILO® mycoprotein ingredients for the aquaculture, pet food and food industries.

The company plans to expand the use of its PEKILO mycoprotein to encompass aquaculture, pet food and human food.

The biotech startup will use the funds to scale the production of its sustainable protein ingredient.

MOA Foodtech and eniferBio, among four other pet care companies will receive funding and mentorship through Purina’s Unleashed Accelerator Program.